The human glucocorticoid receptor: Molecular basis of biologic function

Steroids

Volumn 75, Issue 1, 2010, Pages 1-12

  Nicolaides, Nicolas C ^a   Galata, Zoi ^a   Kino, Tomoshige ^b   Chrousos, George P ^a,b,c   Charmandari, Evangelia ^a,b,c  

^a Biomedical Research Foundation   (Greece)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Generalized glucocorticoid resistance; Human glucocorticoid receptor (hGR); Mutations in the hGR gene; Polymorphisms of the hGR gene

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RECEPTOR SUBUNIT; TRANSCRIPTION FACTOR AP 1;

ACETYLATION; AMINO ACID SUBSTITUTION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CRYSTAL STRUCTURE; DIMERIZATION; DNA BINDING; GENE MUTATION; HUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SUMOYLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UBIQUITINATION; ZINC FINGER MOTIF;

DRUG RESISTANCE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; MUTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, GLUCOCORTICOID; RESPONSE ELEMENTS;

EID: 71849112377     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2009.09.002     Document Type: Review

References (127)

1. Clark J.K., Schrader W.T., and O'Malley B.W. Mechanism of steroid hormones. In: Wilson J.D., and Foster D.W. (Eds). Williams textbook of endocrinology (1992), WB Sanders Co., Philadelphia 35-90
2. Chrousos G.P., Charmandari E., and Kino T. Glucocorticoid action networks-an introduction to systems biology. J Clin Endocrinol Metab 89 (2004) 563-564
3. Chrousos G.P. The glucocorticoid receptor gene, longevity, and the complex disorders of Western societies. Am J Med 117 (2004) 204-207
4. Galon J., Franchimont D., Hiroi N., Frey G., Boettner A., Ehrhart-Bornstein M., et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16 1 (2002) 61-71
5. Zhou J., and Cidlowski J.A. The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 70 5-7 (2005) 407-417
6. Duma D., Jewell C.M., and Cidlowski J.A. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol 102 1-5 (2006) 11-21
7. Hollenberg S.M., Weinberger C., Ong E.S., Cerelli G., Oro A., Lebo R., et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318 (1985) 635-641
8. Kino T., Manoli I., Kelkar S., Wang Y., Su Y.A., and Chrousos G.P. Glucocorticoid receptor (GR) β has intrinsic, GRα-independent transcriptional activity. Biochem Biophys Res Commun 381 4 (2009) 671-675
9. Oakley R.H., Jewell C.M., Yudt M.R., Bofetiado D.M., and Cidlowski J.A. The dominant negative activity of the human glucocorticoid receptor β isoform. Specificity and mechanisms of action. J Biol Chem 274 39 (1999) 27857-27866
10. Bledsoe R.K., Montana V.G., Stanley T.B., Delves C.J., Apolito C.J., McKee D.D., et al. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110 (2002) 93-105
11. Tanenbaum D.M., Wang Y., Williams S.P., and Sigler P.B. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci USA 95 (1998) 5998-6003
12. Kauppi B., Jakob C., Farnegardh M., Yang J., Ahola H., Alarcon M., et al. The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. J Biol Chem 278 25 (2003) 22748-22754
13. Zhang S., Liang X., and Danielsen M. Role of the C terminus of the glucocorticoid receptor in hormone binding and agonist/antagonist discrimination. Mol Endocrinol 10 1 (1996) 24-34
14. Robin-Jagerschmidt C., Wurtz J.M., Guillot B., Gofflo D., Benhamou B., Vergezac A., et al. Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity. Mol Endocrinol 14 7 (2000 Jul) 1028-1037
15. Rogerson F.M., Yao Y.Z., Elsass R.E., Dimopoulos N., Smith B.J., and Fuller P.J. A critical region in the mineralocorticoid receptor for aldosterone binding and activation by cortisol: evidence for a common mechanism governing ligand binding specificity in steroid hormone receptors. Mol Endocrinol 21 4 (2007) 817-828
16. Charmandari E., Raji A., Kino T., Ichijo T., Tiulpakov A., Zachman K., et al. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity. J Clin Endocrinol Metab 90 6 (2005) 3696-3705
17. Lu N.Z., and Cidlowski J.A. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 18 (2005) 331-342
18. Breslin M.B., Geng D., and Vedeckis W.V. Multiple promoters exist in the human GR gene, one of which is activated by glucocorticoids. Mol Endocrinol 15 (2001) 1381-1395
19. Chrousos G.P., and Kino T. Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci STKE 2005 304 (2005) pe48
20. Pratt W.B. The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J Biol Chem 268 29 (1993) 21455-21458
21. Davies T.H., Ning Y.M., and Sanchez E.R. A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem 277 7 (2002) 4597-4600
22. Brown G.M., Grota L.J., Penney D.P., and Reichlin S. Pituitary-adrenal function in the squirrel monkey. Endocrinology 86 3 (1970) 519-529
23. Denny W.B., Valentine D.L., Reynolds P.D., Smith D.F., and Scammell J.G. Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology 141 11 (2000) 4107-4113
24. Terry L.J., Shows E.B., and Wente S.R. Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science 318 5855 (2007) 1412-1416
25. Bamberger C.M., Schulte H.M., and Chrousos G.P. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 17 3 (1996) 245-261
26. Schaaf M.J., and Cidlowski J.A. Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 83 1-5 (2002) 37-48
27. Jonat C., Rahmsdorf H.J., Park K.K., Cato A.C., Gebel S., Ponta H., et al. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62 6 (1990) 1189-1204
28. Scheinman R.I., Gualberto A., Jewell C.M., Cidlowski J.A., and Baldwin Jr. A.S. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol Cell Biol 15 2 (1995) 943-953
29. Kino T., and Chrousos G.P. Tissue-specific glucocorticoid resistance-hypersensitivity syndromes: multifactorial states of clinical importance. J Allergy Clin Immunol 109 4 (2002) 609-613
30. Gottlicher M., Heck S., and Herrlich P. Transcriptional crosstalk, the second mode of steroid hormone receptor action. J Mol Med 76 (1998) 480-489
31. Jonat C., Rahmsdorf H.J., Park K.K., Cato A.C., Gebel S., Ponta H., et al. Anti-tumor promotion and anti-inflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62 (1990) 1189-1204
32. Schule R., Rangarajan P., Kliewer S., Ransone L.J., Bolado J., Yang N., et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62 (1990) 1217-1226
33. Konig H., Ponta H., Rahmsdorf H.J., and Herrlich P. Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J 11 (1992) 2241-2246
34. Heck S., Kullmann M., Gast A., Ponta H., Rahmsdorf H.J., Herrlich P., et al. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J 13 (1994) 4087-4095
35. McKay L.I., and Cidlowski J.A. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 20 (1999) 435-459
36. Stocklin E., Wissler M., Gouilleux F., and Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383 (1996) 726-728
37. Liu J., and DeFranco D.B. Protracted nuclear export of glucocorticoid receptor limits its turnover and does not require the exportin 1/CRM1-directed nuclear export pathway. Mol Endocrinol 14 1 (2000) 40-51
38. Carrigan A., Walther R.F., Salem H.A., Wu D., Atlas E., Lefebvre Y.A., et al. An active nuclear retention signal in the glucocorticoid receptor functions as a strong inducer of transcriptional activation. J Biol Chem 282 15 (2007) 10963-10971
39. Black B.E., Holaska J.M., Rastinejad F., and Paschal B.M. DNA binding domains in diverse nuclear receptors function as nuclear export signals. Curr Biol 11 22 (2001) 1749-1758
40. 2+-dependent nuclear export mediated by calreticulin. Mol Cell Biol 22 17 (2002) 6286-6297
41. Lieberman B.A., Bona B.J., Edwards D.P., and Nordeen S.K. The constitution of a progesterone response element. Mol Endocrinol 7 (1993) 515-527
42. Beato M., and Sanchez-Pacheco A. Interaction of steroid hormone receptors with the transcription initiation complex. Endocr Rev 17 (1996) 587-609
43. McKenna N.J., Lanz R.B., and O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20 3 (1999) 321-344
44. McKenna N.J., Xu J., Nawaz Z., Tsai S.Y., Tsai M.J., and O'Malley B.W. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol 69 (1999) 3-12
45. McKenna N.J., and O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108 (2002) 465-474
46. Auboeuf D., Honig A., Berget S.M., and O'Malley B.W. Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 298 (2002) 416-419
47. Heery D.M., Kalkhoven E., Hoare S., and Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387 6634 (1997) 733-736
48. Reichardt H.M., Kaestner K.H., Tuckermann J., Kretz O., Wessely O., Bock R., et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93 (1998) 531-541
49. Cole T.J., Blendy J.A., Monaghan A.P., Krieglstein K., Schmid W., Aguzzi A., et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9 (1995) 1608-1621
50. Reichardt H.M., Tuckermann J.P., Gottlicher M., Vujic M., Weih F., Angel P., et al. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J 20 (2001) 7168-7173
51. Karin M., and Chang L. AP-1-glucocorticoid receptor crosstalk taken to a higher level. J Endocrinol 169 (2001) 447-451
52. Barnes P.J., and Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336 (1997) 1066-1071
53. Didonato J.A., Saatcioglu F., and Karin M. Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids. Am J Respir Crit Care Med 154 (1996) S11-15
54. Ismaili N., and Garabedian M.J. Modulation of glucocorticoid receptor function via phosphorylation. Ann N Y Acad Sci 1024 (2004) 86-101
55. Orti E., Hu L.M., and Munck A. Kinetics of glucocorticoid receptor phosphorylation in intact cells. Evidence for hormone-induced hyperphosphorylation after activation and recycling of hyperphosphorylated receptors. J Biol Chem 268 (1993) 7779-7784
56. Wang Z., Frederick J., and Garabedian M.J. Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo. J Biol Chem 277 (2002) 26573-26580
57. Miller A.L., Webb M.S., Copik A.J., Wang Y., Johnson B.H., Kumar R., et al. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol 19 (2005) 1569-1583
58. Kino T., Ichijo T., Amin N.D., Kesavapany S., Wang Y., Kim N., et al. Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol 21 7 (2007) 1552-1568
59. Rogatsky I., Waase C.L., and Garabedian M.J. Phosphorylation and inhibition of rat glucocorticoid receptor transcriptional activation by glycogen synthase kinase-3 (GSK-3). Species-specific differences between human and rat glucocorticoid receptor signaling as revealed through GSK-3 phosphorylation. J Biol Chem 273 23 (1998) 14315-14321
60. Galliher-Beckley A.J., Williams J.G., Collins J.B., and Cidlowski J.A. Glycogen synthase kinase 3β-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Mol Cell Biol 28 24 (2008) 7309-7322
61. Rogatsky I., Logan S.K., and Garabedian M.J. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc Natl Acad Sci USA 95 5 (1998) 2050-2055
62. Itoh M., Adachi M., Yasui H., Takekawa M., Tanaka H., and Imai K. Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol Endocrinol 16 10 (2002) 2382-2392
63. Dennis A.P., and O'Malley B.W. Rush hour at the promoter: how the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription. J Steroid Biochem Mol Biol 93 (2005) 139-151
64. Kinyamu H.K., Chen J., and Archer T.K. Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors. J Mol Endocrinol 34 (2005) 281-297
65. Gillette T.G., Gonzalez F., Delahodde A., Johnston S.A., and Kodadek T. Physical and functional association of RNA polymerase II and the proteasome. Proc Natl Acad Sci USA 101 (2004) 5904-5909
66. Deroo B.J., Rentsch C., Sampath S., Young J., DeFranco D.B., and Archer T.K. Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Mol Cell Biol 22 12 (2002) 4113-4123
67. Kino T., Liou S.H., Charmandari E., and Chrousos G.P. Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function. Mol Med 10 7-12 (2004) 80-88
68. Ito K., Yamamura S., Essilfie-Quaye S., Cosio B., Ito M., Barnes P.J., et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression. J Exp Med 203 1 (2006) 7-13
69. Nader N., Chrousos G.P., and Kino T. Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications. FASEB J 23 5 (2009) 1572-1583
70. Le Drean Y., Mincheneau N., Le Goff P., and Michel D. Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. Endocrinology 143 9 (2002) 3482-3489
71. Göttlicher M., Heck S., Doucas V., Wade E., Kullmann M., Cato A.C., et al. Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor. Steroids 61 4 (1996) 257-262
72. Cho S., Kagan B.L., Blackford Jr. J.A., Szapary D., and Simons Jr. S.S. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9. Mol Endocrinol 19 2 (2005) 290-311
73. Tian S., Poukka H., Palvimo J.J., and Jänne O.A. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. Biochem J 367 Pt 3 (2002) 907-911
74. Holmstrom S., Van Antwerp M.E., and Iñiguez-Lluhi J.A. Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy. Proc Natl Acad Sci USA 100 26 (2003) 15758-15763
75. Kino T., and Chrousos G.P. Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. J Endocrinol 169 3 (2001) 437-445
76. Chrousos G.P. Hormone resistance and hypersensitivity states. In: Chrousos G.P., Olefsky J.M., and Samols E. (Eds). Modern endocrinology series (2002), Lippincott, Williams & Wilkins, Philadelphia, PA 542
77. Kino T., De Martino M.U., Charmandari E., Mirani M., and Chrousos G.P. Tissue glucocorticoid resistance/hypersensitivity syndromes. J Steroid Biochem Mol Biol 85 2-5 (2003) 457-467
78. Chrousos G.P., and Kino T. Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress 10 2 (2007) 213-219
79. Vingerhoeds A.C., Thijssen J.H., and Schwarz F. Spontaneous hypercortisolism without Cushing's syndrome. J Clin Endocrinol Metab 43 5 (1976) 1128-1133
80. Chrousos G.P., Vingerhoeds A., Brandon D., Eil C., Pugeat M., DeVroede M., et al. Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. J Clin Invest 69 6 (1982) 1261-1269
81. Chrousos G.P., Detera-Wadleigh S.D., and Karl M. Syndromes of glucocorticoid resistance. Ann Intern Med 119 11 (1993) 1113-1124
82. Kino T., Vottero A., Charmandari E., and Chrousos G.P. Familial/sporadic glucocorticoid resistance syndrome and hypertension. Ann N Y Acad Sci 970 (2002) 101-111
83. Charmandari E., Kino T., and Chrousos G.P. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms. Ann N Y Acad Sci 1024 (2004) 168-181
84. Charmandari E., and Kino T. Novel causes of generalized glucocorticoid resistance. Horm Metab Res 39 6 (2007) 445-450
85. Charmandari E., Kino T., Ichijo T., and Chrousos G.P. Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab 93 5 (2008) 1563-1572
86. Karl M., Lamberts S.W., Koper J.W., Katz D.A., Huizenga N.E., Kino T., et al. Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc Assoc Am Physicians 108 4 (1996) 296-307
87. Hurley D.M., Accili D., Stratakis C.A., Karl M., Vamvakopoulos N., Rorer E., et al. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 87 2 (1991) 680-686
88. Karl M., Lamberts S.W., Detera-Wadleigh S.D., Encio I.J., Stratakis C.A., Hurley D.M., et al. Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metab 76 3 (1993) 683-689
89. Malchoff D.M., Brufsky A., Reardon G., McDermott P., Javier E.C., Bergh C.H., et al. A mutation of the glucocorticoid receptor in primary cortisol resistance. J Clin Invest 91 5 (1993) 1918-1925
90. Kino T., Stauber R.H., Resau J.H., Pavlakis G.N., and Chrousos G.P. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking. J Clin Endocrinol Metab 86 11 (2001) 5600-5608
91. Ruiz M., Lind U., Gafvels M., Eggertsen G., Carlstedt-Duke J., Nilsson L., et al. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol (Oxf) 55 3 (2001) 363-371
92. Mendonca B.B., Leite M.V., de Castro M., Kino T., Elias L.L., Bachega T.A., et al. Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene. J Clin Endocrinol Metab 87 4 (2002) 1805-1809
93. Vottero A., Kino T., Combe H., Lecomte P., and Chrousos G.P. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. J Clin Endocrinol Metab 87 6 (2002) 2658-2667
94. Charmandari E., Kino T., Vottero A., Souvatzoglou E., Bhattacharyya N., and Chrousos G.P. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission and clinical phenotype. J Clin Endocrinol Metab 89 4 (2004) 1939-1949
95. Charmandari E., Kino T., Ichijo T., Zachman K., Alatsatianos A., and Chrousos G.P. Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRαR477H and hGRαG679S associated with generalized glucocorticoid resistance. J Clin Endocrinol Metab 91 4 (2006) 1535-1543
96. Charmandari E., Kino T., Ichijo T., Jubiz W., Mejia L., Zachman K., et al. A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance. J Clin Endocrinol Metab 92 10 (2007) 3986-3990
97. Savory J.G., Hsu B., Laquian I.R., Giffin W., Reich T., Hache R.J., et al. Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol Cell Biol 19 2 (1999) 1025-1037
98. Picard D., and Yamamoto K.R. Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J 6 11 (1987) 3333-3340
99. Qi M., Hamilton B.J., and DeFranco D. v-mos oncoproteins affect the nuclear retention and reutilization of glucocorticoid receptors. Mol Endocrinol 3 8 (1989) 1279-1288
100. Wikstrom A.C., Bakke O., Okret S., Bronnegard M., and Gustafsson J.A. Intracellular localization of the glucocorticoid receptor: evidence for cytoplasmic and nuclear localization. Endocrinology 120 4 (1987) 1232-1242
101. Ding X.F., Anderson C.M., Ma H., Hong H., Uht R.M., Kushner P.J., et al. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol Endocrinol 12 2 (1998) 302-313
102. Hong H., Kohli K., Garabedian M.J., and Stallcup M.R. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17 5 (1997) 2735-2744
103. Hong H., Kohli K., Trivedi A., Johnson D.L., and Stallcup M.R. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci USA 93 10 (1996) 4948-4952
104. Lamberts S.W., Huizenga A.T., de Lange P., de Jong F.H., and Koper J.W. Clinical aspects of glucocorticoid sensitivity. Steroids 61 4 (1996) 157-160
105. Smit P., Russcher H., de Jong F.H., Brinkmann A.O., Lamberts S.W., and Koper J.W. Differential regulation of synthetic glucocorticoids on gene expression levels of glucocorticoid-induced leucine zipper and interleukin-2. J Clin Endocrinol Metab 90 5 (2005) 2994-3000
106. van Rossum E.F., and Lamberts S.W. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res 59 (2004) 333-357
107. Koper J.W., Stolk R.P., de Lange P., Huizenga N.A., Molijn G.J., Pols H.A., et al. Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet 99 5 (1997) 663-668
108. Huizenga N.A., Koper J.W., De Lange P., Pols H.A., Stolk R.P., Burger H., et al. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 83 1 (1998) 144-151
109. Lin R.C., Wang X.L., Dalziel B., Caterson I.D., and Morris B.J. Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant. Obes Res 11 6 (2003) 802-808
110. Di Blasio A.M., van Rossum E.F., Maestrini S., Berselli M.E., Tagliaferri M., Podestà F., et al. The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients. Clin Endocrinol (Oxf) 59 1 (2003) 68-74
111. Roussel R., Reis A.F., Dubois-Laforgue D., Bellanné-Chantelot C., Timsit J., and Velho G. The N363S polymorphism in the glucocorticoid receptor gene is associated with overweight in subjects with type 2 diabetes mellitus. Clin Endocrinol (Oxf) 59 2 (2003) 237-241
112. Dobson M.G., Redfern C.P., Unwin N., and Weaver J.U. The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. J Clin Endocrinol Metab 86 5 (2001) 2270-2274
113. Lin R.C., Wang X.L., and Morris B.J. Association of coronary artery disease with glucocorticoid receptor N363S variant. Hypertension 41 3 (2003) 404-407
114. Buemann B., Vohl M.C., Chagnon M., Chagnon Y.C., Gagnon J., Pérusse L., et al. Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res 5 3 (1997 May) 186-192
115. Rosmond R., Chagnon Y.C., Holm G., Chagnon M., Pérusse L., Lindell K., et al. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res 8 3 (2000) 211-218
116. Ukkola O., Pérusse L., Chagnon Y.C., Després J.P., and Bouchard C. Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Québec Family Study. Int J Obes Relat Metab Disord 25 9 (2001) 1332-1339
117. Weaver J.U., Hitman G.A., and Kopelman P.G. An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women. J Mol Endocrinol 9 3 (1992) 295-300
118. van Rossum E.F., Koper J.W., van den Beld A.W., Uitterlinden A.G., Arp P., Ester W., et al. Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin Endocrinol (Oxf) 59 5 (2003) 585-592
119. Russcher H., Smit P., van den Akker E.L., van Rossum E.F., Brinkmann A.O., de Jong F.H., et al. Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. J Clin Endocrinol Metab 90 10 (2005) 5804-5810
120. van Rossum E.F., Koper J.W., Huizenga N.A., Uitterlinden A.G., Janssen J.A., Brinkmann A.O., et al. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 51 10 (2002) 3128-3134
121. van Rossum E.F., Feelders R.A., van den Beld A.W., Uitterlinden A.G., Janssen J.A., Ester W., et al. Association of the ER22/23EK polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men. Am J Med 117 3 (2004) 158-162
122. van Rossum E.F., Voorhoeve P.G., te Velde S.J., Koper J.W., Delemarre-van de Waal H.A., Kemper H.C., et al. The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J Clin Endocrinol Metab 89 8 (2004) 4004-4009
123. Russcher H., van Rossum E.F., de Jong F.H., Brinkmann A.O., Lamberts S.W., and Koper J.W. Increased expression of the glucocorticoid receptor-A translational isoform as a result of the ER22/23EK polymorphism. Mol Endocrinol 19 7 (2005) 1687-1696
124. Detera-Wadleigh S.D., Encio I.J., Rollins D.Y., Coffman D., and Wiesch D. A TthIII1 polymorphism on the 5′ flanking region of the glucocorticoid receptor gene (GRL). Nucleic Acids Res 19 8 (1991) 1960
125. van Rossum E.F., Roks P.H., de Jong F.H., Brinkmann A.O., Pols H.A., Koper J.W., et al. Characterization of a promoter polymorphism in the glucocorticoid receptor gene and its relationship to three other polymorphisms. Clin Endocrinol (Oxf) 61 5 (2004) 573-581
126. Charmandari E., Ichijo T., Jubiz W., Baid S., Zachman K., Chrousos G.P., et al. A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression. J Clin Endocrinol Metab 93 12 (2008) 4963-4968
127. Syed A.A., Irving J.A., Redfern C.P., Hall A.G., Unwin N.C., White M., et al. Association of glucocorticoid receptor polymorphism A3669G in exon 9beta with reduced central adiposity in women. Obesity (Silver Spring) 14 5 (2006) 759-764